Drug Shortage Report for TEVA-TELMISARTAN

Last updated on 2020-05-08 History
Report ID 67225
Drug Identification Number 02320185
Brand name TEVA-TELMISARTAN
Common or Proper name TELMISARTAN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TELMISARTAN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-20
Estimated end date 2020-06-30
Actual end date 2020-05-07
Shortage status Resolved
Updated date 2020-05-08
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2020-05-08 French Compare
v34 2020-05-08 English Compare
v33 2020-05-01 French Compare
v32 2020-05-01 English Compare
v31 2020-04-16 French Compare
v30 2020-04-16 English Compare
v29 2020-04-02 French Compare
v28 2020-04-02 English Compare
v27 2020-02-13 French Compare
v26 2020-02-13 English Compare
v25 2020-01-09 French Compare
v24 2020-01-09 English Compare
v23 2019-12-12 French Compare
v22 2019-12-12 English Compare
v21 2019-10-31 French Compare
v20 2019-10-31 English Compare
v19 2019-10-03 French Compare
v18 2019-10-03 English Compare
v17 2019-08-22 French Compare
v16 2019-08-22 English Compare

Showing 1 to 20 of 35